Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
株式のランク #18091
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
株価
$4.47
最終同期: 2025-08-20
時価総額
$213.06M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 CARGO Therapeutics, Inc. Common Stock (CRGX)

カテゴリー

CARGO Therapeutics, Inc. Common Stock(CRGX)の配当利回りの履歴
CARGO Therapeutics, Inc. Common Stock(銘柄コード: CRGX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
CARGO Therapeutics, Inc. Common Stock(CRGX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)